The phase I trial of IVA-337 in healthy volunteers.

Next Previous
Trial Profile

The phase I trial of IVA-337 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Aug 2015

At a glance

  • Drugs Lanifibranor (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Inventiva Pharma

    • Most Recent Events

    • 14 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top